On August 24, 2023 Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, reported that the Company will present at two healthcare industry conferences in September 2023 (Press release, Carisma Therapeutics, AUG 24, 2023, View Source [SID1234634688]). These conferences include:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

8th Annual CAR-TCR Summit

Michael Klichinsky, PharmD, PhD, Co-Founder and Chief Scientific Officer, will give a presentation during the summit.
"CAR-M: Pioneering a Novel Approach for Solid Tumor Immunotherapy"
Friday, September 1, 2023 at 9:20 am ET
Boston, Massachusetts

CAR-T Consortia Seminar

Michael Klichinsky, PharmD, PhD, Co-Founder and Chief Scientific Officer, will give a presentation during the meeting.
"CAR Macrophages"
Tuesday, September 19, 2023 at 12:00 pm ET
Virtual
A replay of webcasts, when available, will be posted and archived at Carisma’s Investor Events webpage for a limited time following the event.